Variant Creutzfeldt‐Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies

Abstract

The large uncertainties involved in these analyses mean that estimates must be interpreted cautiously, but the data does suggest that donor deferral may exclude more donations from donors potentially infected with vCJD than the corresponding increase, caused by donor replacement, of window-period donations possibly infected with HIV, HCV or HBV.